About
Technology
Issues
FAQ
Links
Official Page
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.